What is the success rate for microvascular decompression in multiple sclerosis trigeminal neuralgia?
Microvascular decompression (MVD) is a surgery that moves blood vessels away from the trigeminal nerve to stop pain. For patients with multiple sclerosis (MS) and trigeminal neuralgia, this procedure has traditionally been viewed with caution because MS causes nerve damage that is different from the simple pressure MVD fixes. Recent research suggests MVD can still work for some patients, but the success rates vary significantly depending on the study and how long you follow them.
What the research says
Other factors also influence the outcome. A 2020 study found that higher pain intensity before surgery was linked to worse results after MVD in MS patients 6. Additionally, a 2025 review noted that while MVD models perform well for prediction, the definition of recurrence varies, which can affect how success is measured 1. Because of these variations, doctors often use a flowchart to decide if MVD is the right choice compared to other options like balloon compression, which showed a 65% initial pain-free rate in MS patients 3.
What to ask your doctor
- What is your specific success rate for MVD in patients with multiple sclerosis based on your own experience?
- How do you define long-term success for MS-related trigeminal neuralgia in your practice?
- What factors in my specific case, such as disease duration or pain severity, might affect the outcome of MVD?
- Is MVD a better option than balloon compression or radiosurgery for my specific type of MS-related pain?
- What are the risks of nerve damage or numbness if I choose MVD over other procedures?
This question is drawn from common patient questions about Neurology and answered using cited medical research. We do not provide individualized advice.